• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2100230 巴瑞替尼片 baricitinib Tablet Chemical Drugs Supplementary Application 2021-03-31 Eli Lilly Nederland B.V. Eli Lilly Nederland BV In Review 2021-03-30 view
JYHB2100231 巴瑞替尼片 baricitinib Tablet Chemical Drugs Supplementary Application 2021-03-31 Eli Lilly Nederland B.V. Eli Lilly Nederland BV In Review 2021-03-30 view
JYSB1900305 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2019-11-02 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2021-01-21 view
JYSB2000005 度拉糖肽注射液 dulaglutide Injection Biological Products Supplementary Application 2020-01-15 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2021-01-21 view
JYSB1900304 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2019-11-02 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2021-01-21 view
JYSB1900303 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2019-11-08 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2021-01-21 view
JYSB1900302 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2019-11-08 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2021-01-21 view
JYSB2000006 度拉糖肽注射液 dulaglutide Injection Biological Products Supplementary Application 2020-01-15 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2021-01-21 view
JYHB2001161 巴瑞替尼片 baricitinib Tablet Chemical Drugs Supplementary Application 2020-07-04 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2020-12-10 view
JYHB2001160 巴瑞替尼片 baricitinib Tablet Chemical Drugs Supplementary Application 2020-07-04 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2020-12-10 view
JYSB2000469 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2020-09-23 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2020-11-20 view
JYSB2000468 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2020-09-23 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2020-11-20 view
JYHB2002157 他达拉非片 tadalafil Tablet Chemical Drugs Supplementary Application 2020-10-27 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2020-11-16 view
JYHB2002158 他达拉非片 tadalafil Tablet Chemical Drugs(1) Supplementary Application 2020-10-27 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2020-11-09 view
JYSB2000050 度拉糖肽注射液 dulaglutide Injection Biological Products Supplementary Application 2020-02-19 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2020-09-27 view
JYSB2000049 度拉糖肽注射液 dulaglutide Injection Biological Products Supplementary Application 2020-02-19 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2020-09-27 view
JYSB2000443 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2020-09-08 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2020-09-18 view
JYSB2000444 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2020-09-08 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2020-09-18 view
JYSB2000419 度拉糖肽注射液 dulaglutide Injection Biological Products Supplementary Application 2020-08-24 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2020-09-02 view
JYSB2000385 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2020-08-21 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2020-09-02 view